TREM2 and Alzheimer disease: Impairments in expression, recycling, and trafficking of phagocytic receptors such as TREM2 and CD36 contribute to neurodegeneration (4, 53, 54), while their upregulation results in improved phagocytosis and decelerated AD pathogenesis (55–58).